Last reviewed · How we verify

Cyclohexal (CYCLOBARBITAL)

FDA-approved withdrawn Small molecule Quality 6/100

At a glance

Generic nameCYCLOBARBITAL
Drug classcyclobarbital
ModalitySmall molecule
Therapeutic areaNeuroscience
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: